Patents by Inventor Hongying Zhen

Hongying Zhen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ABCG2 monoclonal antibody and uses thereof
    Patent number: 10611847
    Abstract: Disclosed are an ABCG2 monoclonal antibody having the effects for resisting against tumors and for reversing drug resistance of the tumors, and uses thereof in novel tumor resisting drugs. Also disclosed is a new antigen sequence, used for inducing generation of a monoclonal antibody or a polyclonal antibody for the ABCG2. In addition, disclosed is a hybridoma for generating the ABCG2 monoclonal antibody having the effects for resisting against tumors and for reversing drug resistance of the tumors.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: April 7, 2020
    Assignee: PEKING UNIVERSITY
    Inventor: Hongying Zhen
  • ABCG2 MONOCLONAL ANTIBODY AND USES THEREOF
    Publication number: 20190248912
    Abstract: Disclosed are an ABCG2 monoclonal antibody having the effects for resisting against tumors and for reversing drug resistance of the tumors, and uses thereof in novel tumor resisting drugs. Also disclosed is a new antigen sequence, used for inducing generation of a monoclonal antibody or a polyclonal antibody for the ABCG2. In addition, disclosed is a hybridoma for generating the ABCG2 monoclonal antibody having the effects for resisting against tumors and for reversing drug resistance of the tumors.
    Type: Application
    Filed: September 13, 2017
    Publication date: August 15, 2019
    Applicant: PEKING UNVERSITY
    Inventor: Hongying ZHEN